In this chapter, the original descriptions and pre-molecular studies of tri
osephosphate isomerase (TPI) deficiency are summarized, and the molecular a
spects of the disease presented. The gene is well characterized, and severa
l mutations have been described. Structure-function studies have led to an
increased understanding of impaired catalysis. All kindreds that have been
studied with the predominant Glu104Asp mutation are linked by a common hapl
otype, indicating descent from a common ancestor. Variant upstream substitu
tions occur in high frequency in persons of African and East Asian lineage
and in lower Frequency in other groups, but the possible role, if any, of t
hese variants in clinical TPI deficiency requires further investigation. Th
e possible contribution of deviant lipid metabolism to the pathogenesis of
the disorder has been extensively investigated, and an intriguing new area
of inquiry is the apparent cell-to-cell transfer of enzyme in cell culture
systems, raising the question of the feasibility of enzyme or gene replacem
ent therapy.